QIAGEN at the ASHG 2020 virtual meeting
QIAGEN at the ASHG 2020 virtual meeting
CoLab session: Wednesday, October 28, 12 p.m. EDT
Speaker: Dr. Özlem Karalay, Senior Scientist, Digital PCR Assay Development, QIAGEN GmbH
Abstract:
Copy number variations (CNVs) are key players inducing natural genetic diversity as well as biological dysfunction in humans, often associated with complex diseases such as cancer, obesity, neurodegenerative and autoimmune diseases. The quantitative analyses of CNVs at disease-associated loci, therefore, provide insights into molecular mechanisms of diseases and offers potential for the discovery of novel biomarkers.
Digital PCR (dPCR) enables accurate detection of copy numbers in the genome, making it an indispensable tool for diagnosis and subsequent analysis of copy number alterations underlying disease progression.
In this webinar, we will focus on accurate and high-resolution detection of cancer-related CNVs using cell line models and other sample types. We will describe CNV analysis using QIAGEN’s QIAcuity dPCR system, including a quick demo using the QIAcuity dPCR Software Suite. We will provide insights into experimental optimization as well as other aspects of CNV analysis.
Learning objectives:
Educational seminar: Tuesday, October 27, 2:30 p.m. EDT
Speaker: Michael Hadjisavas, Ph.D., Vice President Product Management, Genomics, QIAGEN
Peter Hahn, Ph.D., Associate Director, R&D, NGS technology development, QIAGEN
Jim Hayes, Sr. Clinical Field Application Scientist, Applied Advanced Genomics, QIAGEN
Julie Deschenes, Ph.D., M.B.A, Director, Global Product Management, Clinical Genomics Platform & Hereditary Cancer, QIAGEN
Abstract:
What if your lab could perform exome sequencing with the same sensitivity and efficiency of targeted sequencing? The new integrated QIAseq Human Exome TR Insights solution from QIAGEN delivers the best of both worlds. Consisting of three seamlessly integrated components – the QIAseq Human Exome Panel, QIAGEN CLC Genomics Workbench and QCI Interpret Translational – this innovative solution combines highly specific and uniform exome coverage with streamlined secondary analysis, rapid variant filtering and variant annotation to help labs quickly and confidently deliver disease-related insights at scale. Join us for a presentation where we will discuss the new solution in detail, focusing on the following:
The integrated QIAseq Human Exome solution translates insights into better outcomes, enabling labs to scale up efficiently.
All-day Thursday, October 29: Discussion lounge
Join us for coffee, a compelling conversation and a free QIAGEN face mask! Discover how our innovations can help you overcome your human genetics research challenges. Attend our Discussion Lounge to chat about the following topics: